PI
BIVV

Putnam Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Putnam Investments’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,477,681
Closed -$79.7M – 1244
2017
Q4 		$79.7M Sell
1,477,681
-55,941
-4% -$3.06M 0.18% 138
2017
Q3 		$87.5M Buy
1,533,622
+496,224
+48% +$29.1M 0.2% 125
2017
Q2 		$62.4M Buy
+1,037,398
New +$59.1M 0.15% 146

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Putnam Investments's BIVV Position: Q1 2018 in Review

Putnam Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,477,681 shares — an estimated $79.7M sold.

Putnam Investments first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $87.5M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Putnam Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Putnam Investments sold 1,477,681 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $79.7M.
  • Putnam Investments first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Putnam Investments's Bioverativ Inc. Common Stock position peaked at $87.5M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Putnam Investments's 13F filing for Q1 2018, filed 15 May 2018.